Nextrials Launches Prism 3.0


San Ramon, CA-September 30, 2009

Nextrials, Inc.

, has upgraded its electronic data capture and clinical trial management platform, Prism.  In addition to its new user interface, Prism now offers expanded functionality and interoperability with electronic health records from multiple vendors.

Prism users will see differences to its start page, where researchers can now evaluate project data from multiple studies organized into modules that can be collapsed and expanded for review. The “at a glance” statistics roll-up bar is intended to provide users with fast facts, such as enrollment status and data quality metrics. And with Prism’s newly streamlined structure, pop-up windows have been reduced in favor of intuitive layers within the browser.
A significant change to Prism is its interoperability with data platforms more traditionally found within the healthcare environment for creating and managing electronic medical records. This gives life science companies many more options for implementing studies using patients and sites. Also, major incentives included in the American Recovery and Reinvestment Act (ARRA) will further promote the adoption of electronic medical records.
Nextrials expanded Prism’s report generation functionality earlier in the year to give users more powerful data mining capabilities.  This ad hoc reporting feature has been further enhanced so that customers can now share reports with others, more easily monitor study progress and even drill down to analyze underlying data.

Prism 3.0 will continue to support mobile access to data via the Apple iPhone. Nextrials expects Prism 3.0 to be in general availability before the end of the year.  However, attendees at the 2009 Society for Clinical Data Management Annual Conference, being held at the Westin Seattle (WA) Hotel October 4-6, can get a first look at Nextrials’ Prism 3.0 in booth #301 and #303.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
Related Content
© 2024 MJH Life Sciences

All rights reserved.